A Paradigm Shift to Prevent and Treat Alzheimer's Disease: From Monotargeting Pharmaceuticals to Pleiotropic Plant Polyphenols

★★★★★ 5.0 105 reviews

US$25.85
Price when purchased online
Free shipping Free 30-day returns

Sold and shipped by www.igniteselection.com
We aim to show you accurate product information. Manufacturers, suppliers and others provide what you see here.
US$25.85
Price when purchased online
Free shipping Free 30-day returns

How do you want your item?
You get 30 days free! Choose a plan at checkout.
Shipping
Arrives Jul 23
Free
Pickup
Check nearby
Delivery
Not available

Sold and shipped by www.igniteselection.com
Free 30-day returns Details

Product details

Management number 233516494 Release Date 2026/06/27 List Price US$25.85 Model Number 233516494
Category

A Paradigm Shift to Prevent and Treat Alzheimer’s Disease: From Monotargeting Pharmaceuticals to Pleiotropic Plant Polyphenols is the first book to systematically exhibit the powerful pleiotropic pharmacological effects on Alzheimer’s disease of plant-based compounds from ancient foods that humans have been consuming safely with substantial health benefits for thousands of years. These plant-based compounds include curcuminoids from turmeric, resveratrol from red wine and grape seed extract from other grape products, epigallocatechin-gallate (EGCG) from green tea, and oleocanthal and oleuropein from olive oil, in addition to a special extract, EGb 761, from the leaves of Ginkgo biloba, the oldest living species of tree on earth. This book also presents a new analytical framework that convincingly favors a multi-targeting ("pleiotropic") approach to the prevention and treatment of complex chronic diseases, in contrast to the mono-targeting of the pharmaceutical model. A Paradigm Shift to Prevent and Treat Alzheimer’s Disease is a unique and exciting resource for pharmaceutical scientists, pharmacologists, neurologists, general practitioners, research scientists in various medical and life sciences, healthcare professionals in clinical and executive positions, conventional medical schools, schools of naturopathic medicine, healthcare and medical journalists, executives in both national public healthcare systems and private insurers, and informed general readers. Presents carefully compiled evidence supporting the need to shift from pharmaceutical-based mono-targeting to plant polyphenol-based pleiotropic targeting for the prevention and treatment of Alzheimer’s diseaseIncludes valuable tables that aggregate pleiotropic pharmacological effects of the plant polyphenols on Alzheimer’s disease-related pathogenic hallmarksHighlights regulatory aspects and discusses the challenges and potential solutions with respect to bioavailability of certain plant polyphenols Read more

ISBN10 0128122595
ISBN13 978-0128122594
Edition 1st
Language English
Publisher Academic Press
Dimensions 7.52 x 0.66 x 9.25 inches
Item Weight 1.35 pounds
Print length 290 pages
Publication date August 2, 2017

Correction of product information

If you notice any omissions or errors in the product information on this page, please use the correction request form below.

Correction Request Form

Customer ratings & reviews

5 out of 5
★★★★★
105 ratings | 43 reviews
How item rating is calculated
View all reviews
5 stars
90% (95)
4 stars
0% (0)
3 stars
0% (0)
2 stars
0% (0)
1 star
10% (11)
Sort by

There are currently no written reviews for this product.